OBAT Stock Overview

PT Brigit Biofarmaka Teknologi Tbk provides manufacturing services for herbal medicine, herbal honey, skincare, cosmetics, botanical tea, and functional powdered drinks in Indonesia. More details

OBAT fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	0/6
Past Performance	5/6
Financial Health	5/6
Dividends	2/6

Rewards

Price-To-Earnings ratio (8.9x) is below the ID market (15.3x)

Earnings grew by 100% over the past year

Risk Analysis

High level of non-cash earnings

Does not have a meaningful market cap (IDR272B)

Volatile share price over the past 3 months compared to the ID market

Dividend of 4.93% is not well covered by free cash flows

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

PT Brigit Biofarmaka Technologi Tbk Competitors

Price History & Performance

Summary of share price highs, lows and changes for Brigit Biofarmaka Technologi
Historical stock prices
Current Share Price	Rp454.00
52 Week High	Rp1,030.00
52 Week Low	Rp308.00
Beta	0
1 Month Change	-10.10%
3 Month Change	-24.33%
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	4.13%

Recent updates

Shareholder Returns

	OBAT	ID Personal Products	ID Market
7D	-2.6%	-1.8%	-1.7%
1Y	n/a	-22.1%	0.9%

Return vs Industry: Insufficient data to determine how OBAT performed against the ID Personal Products industry.

Return vs Market: Insufficient data to determine how OBAT performed against the ID Market.

Price Volatility

Is OBAT's price volatile compared to industry and market?
OBAT volatility
OBAT Average Weekly Movement	12.1%
Personal Products Industry Average Movement	6.7%
Market Average Movement	7.1%
10% most volatile stocks in ID Market	13.9%
10% least volatile stocks in ID Market	3.5%

Stable Share Price: OBAT's share price has been volatile over the past 3 months compared to the ID market.

Volatility Over Time: Insufficient data to determine OBAT's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2015	24	Is Heriyanto	www.brigit.co.id

PT Brigit Biofarmaka Teknologi Tbk provides manufacturing services for herbal medicine, herbal honey, skincare, cosmetics, botanical tea, and functional powdered drinks in Indonesia. It also offers hair care products, including shampoo, conditioner, hair mask, hair tonic, hair oil, hair serum, as well as body moisturizer, body cleanser, facial cleanser, moisturizer, essence and serum, face mask, and personal care products. The company was founded in 2015 and is based in Sukoharjo, Indonesia.

PT Brigit Biofarmaka Technologi Tbk Fundamentals Summary

How do Brigit Biofarmaka Technologi's earnings and revenue compare to its market cap?
OBAT fundamental statistics
Market cap	Rp272.40b
Earnings (TTM)	Rp30.63b
Revenue (TTM)	Rp124.99b

8.9x

P/E Ratio

2.2x

P/S Ratio

Is OBAT overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
OBAT income statement (TTM)
Revenue	Rp124.99b
Cost of Revenue	Rp65.95b
Gross Profit	Rp59.04b
Other Expenses	Rp28.41b
Earnings	Rp30.63b

Last Reported Earnings

Mar 31, 2025

Next Earnings Date

n/a

Earnings per share (EPS)	51.06
Gross Margin	47.24%
Net Profit Margin	24.51%
Debt/Equity Ratio	8.1%

How did OBAT perform over the long term?

See historical performance and comparison

Dividends

4.9%

Current Dividend Yield

44%

Payout Ratio

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/06/02 08:51
End of Day Share Price	2025/06/02 00:00
Earnings	2025/03/31
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

PT Brigit Biofarmaka Technologi Tbk is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Brigit Biofarmaka Technologi IDX:OBAT Stock Report